WHO offers a new tool and sets a target to accelerate action against antimicrobial resistance
WHO has launched a global campaign urging governments to adopt a tool to reduce the spread of antimicrobial resistance, adverse events and costs.
The AWaRe tool was developed by the WHO Essential Medicines List to contain rising resistance and make antibiotic use safer and more effective. It classifies antibiotics into three groups – Access, Watch and ... read more
UN environment agency tackles climate change one bite at a time
If we all change the way we eat, we can make significant progress in the fight against climate change. This was the message from the UN environment agency (UNEP) on Sustainable Gastronomy Day- June 18, as it launched a new campaign to encourage healthy and sustainable food choices.... read more
Convicted Physicians Receive Message of Support from World's Doctors
On behalf of millions of physicians globally, the World Medical Association delivered an open message of support to all Turkish doctors, and in particular to those sentenced to prison, for declaring in a press release that 'war is a public health problem'.... read more
Kenya tests woman for Ebola, as Congo, Uganda fight outbreak
Kenya has never experienced an Ebola outbreak and some Kenyan doctors have expressed concern about the country's preparedness to manage the deadly virus. The current outbreak in eastern Congo has caused more than 1,400 deaths since August last year.
Kenyan doctors are testing a patient in western Kenya who has Ebola-like symptoms, as eastern Congo is struggling to control the outbreak and Uganda has reported two deaths from the deadly hemorrhagic fever.... read more
Osteoporosis Drugs May Help Oldest, Sickest Women Most
Frail, very elderly women with osteoporosis may benefit the most from osteoporosis drugs, according to a study published online in JAMA Internal Medicine.
Women older than 80 years with osteoporosis and multiple medical problems or poor prognosis had more than triple the risk for hip fracture in the next 5 years, compared with women in the same age group who had increased fracture risk but no osteoporosis.
... read more
Novel Agent Shows Promise as First Possible Therapy for Achondroplasia
The results are preliminary, but a novel investigative agent has shown promise in a small trial in children for the treatment of achondroplasia, the most common form of human dwarfism.
A phase 2, proof of concept study found that treatment with vosoritide (BioMarin Pharmaceutical), a recombinant C-type natriuretic peptide analogue, demonstrated a favorable safety profile and efficacy at a ... read more